Since the COVID-19 virus outbreak in December 2019, the disease has spread to all countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect this industry in 2020 and 2021.

This report analyses the impact of COVID-19 on this industry. COVID-19 can affect the global market in 3 ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on enterprises and financial markets.

ALSO READ : http://www.marketwatch.com/story/nanopharmaceuticals-market-researc...

This report provides detailed historical analysis of global market for Nanopharmaceuticals from 2015-2020, and provides extensive market forecasts from 2021-2030 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Nanopharmaceuticals market.

Leading players of Nanopharmaceuticals including:
Merck
Pfizer
Novartis
Abbott
GlaxoSmithKline
Roche
Sanofi
Eli Lilly
Astrazeneca
Johnson & Johnson
Celgene
Novavax
Stryker
Gilead Sciences
OSI Pharmaceuticals
Kadmon Pharmaceuticals
Samyang Biopharm
Mitsubishi Pharma
Kaken Pharmaceutical
Selecta Biosciences
Par Pharmaceutical
Cerulean Pharma
Navidea Biopharmaceuticals
Lummy

ALSO READ : http://www.marketwatch.com/story/hemostatic-agents-market-research-...

Market split by Type, can be divided into:
Liposomes
Polymeric Micelles
Solid Lipid Nanoparticles
Microemulsion and Nnanoemulsion
Nanosuspension

Market split by Application, can be divided into:
Cancer and Tumor
Autoimmune Disorders
Inflammation
Others

Market split by Sales Channel, can be divided into:
Direct Channel
Distribution Channel

ALSO READ : http://www.marketwatch.com/story/radiator-fan-shroud-market-researc...

Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America (Brazil, Argentina and Colombia etc.)
Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)

Table of Contents

Chapter 1 Nanopharmaceuticals Market Overview
1.1 Nanopharmaceuticals Definition
1.2 Global Nanopharmaceuticals Market Size Status and Outlook (2015-2030)
1.3 Global Nanopharmaceuticals Market Size Comparison by Region (2015-2030)
1.4 Global Nanopharmaceuticals Market Size Comparison by Type (2015-2030)
1.5 Global Nanopharmaceuticals Market Size Comparison by Application (2015-2030)
1.6 Global Nanopharmaceuticals Market Size Comparison by Sales Channel (2015-2030)
1.7 Nanopharmaceuticals Market Dynamics (COVID-19 Impacts)
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts on Current Market
1.7.5 Post-Strategies of COVID-19 Outbreak
Chapter 2 Nanopharmaceuticals Market Segment Analysis by Player
2.1 Global Nanopharmaceuticals Sales and Market Share by Player (2018-2020)
2.2 Global Nanopharmaceuticals Revenue and Market Share by Player (2018-2020)
2.3 Global Nanopharmaceuticals Average Price by Player (2018-2020)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Nanopharmaceuticals Market Segment Analysis by Type
3.1 Global Nanopharmaceuticals Market by Type
3.1.1 Liposomes
3.1.2 Polymeric Micelles
3.1.3 Solid Lipid Nanoparticles
3.1.4 Microemulsion and Nnanoemulsion
3.1.5 Nanosuspension
3.2 Global Nanopharmaceuticals Sales and Market Share by Type (2015-2020)
3.3 Global Nanopharmaceuticals Revenue and Market Share by Type (2015-2020)
3.4 Global Nanopharmaceuticals Average Price by Type (2015-2020)
3.5 Leading Players of Nanopharmaceuticals by Type in 2020
3.6 Conclusion of Segment by Type
Chapter 4 Nanopharmaceuticals Market Segment Analysis by Application
4.1 Global Nanopharmaceuticals Market by Application
4.1.1 Cancer and Tumor
4.1.2 Autoimmune Disorders
4.1.3 Inflammation
4.1.4 Others
4.2 Global Nanopharmaceuticals Revenue and Market Share by Application (2015-2020)
4.3 Leading Consumers of Nanopharmaceuticals by Application in 2020
4.4 Conclusion of Segment by Application
Chapter 5 Nanopharmaceuticals Market Segment Analysis by Sales Channel
5.1 Global Nanopharmaceuticals Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Nanopharmaceuticals Revenue and Market Share by Sales Channel (2015-2020)
5.3 Leading Distributors/Dealers of Nanopharmaceuticals by Sales Channel in 2020
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Nanopharmaceuticals Market Segment Analysis by Region
6.1 Global Nanopharmaceuticals Market Size and CAGR by Region (2015-2030)
6.2 Global Nanopharmaceuticals Sales and Market Share by Region (2015-2020)
6.3 Global Nanopharmaceuticals Revenue and Market Share by Region (2015-2020)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Nanopharmaceuticals Market Share by Type
6.4.3 North America Nanopharmaceuticals Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Nanopharmaceuticals Market Share by Type
6.5.3 Europe Nanopharmaceuticals Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Nanopharmaceuticals Market Share by Type
6.6.3 Asia-Pacific Nanopharmaceuticals Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Nanopharmaceuticals Market Share by Type
6.7.3 South America Nanopharmaceuticals Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Nanopharmaceuticals Market Share by Type
6.8.3 Middle East & Africa Nanopharmaceuticals Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Nanopharmaceuticals Players
7.1 Merck
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.1.4 COVID-19 Impact on Merck
7.2 Pfizer
7.3 Novartis
7.4 Abbott

…continued

CONTACT DETAILS :

[email protected]

+44 203 500 2763

+1 62 825 80070

971 0503084105